the present invention makes available a substantially pure adhesive protein , comprising the amino acid sequence of seq . id no . 3 or fragments thereof , such as the shorter sequences of seq . id . no . 6 and seq . id . no . 7 , including functionally equivalent fragments or variants thereof . the term “ functionally equivalent ” is meant to encompass proteins , or polynucleotide sequences exhibiting equivalent properties with respect to any desired quality in question , such as the adhesive property , medical properties , the capability to function as an indicator etc . the sequence data surprisingly reveals that the protein has a unique structure and organisation with autocatalytic sites and binding sites for phosphorylation , carbohydrates , and lipids . identification of the protein in the kidney , where it is synthesised , demonstrates that it consists of a 130 kda protein with smaller splicing variants ( as confirmed by nucleotide sequencing ). this also demonstrates that the previous identification of a 203 kda protein in fact was a multimer complex of at least three here identified and characterised proteins . interestingly , these proteins show only low homology to other known proteins , with the highest similarity being 28 % to mucins . post - translational modifications , by glycosylation , account for a minor increase of the molecular mass of the protein . the invention also makes available the dna and cdna sequences , enclosed as seq . id . no . 1 , 4 , and 9 ; and 2 , 5 , and 8 , respectively . the invention also encompasses homologous sequences , and in particular sequences exhibiting a homology greater than 50 %, preferably greater than 70 % and most preferably greater than 90 %. by operatively inserting the coding sequence in a suitable vector , and transfecting a host cell with said vector , the host cell can be made to produce larger quantities of the protein in vitro . e . coli is one suitable host cell . it will however fall within the abilities of a skilled person to select and apply a suitable vector and host cell culture . thus , having access to the sequence data disclosed herein , the large scale production of the protein becomes a question of routine work . according to the present invention , the protein and / or information derived thereof , such as the sequence data , is used for the determination of hormone disrupting or androgenic compounds in the environment . one embodiment of the invention is a method for the detection of androgenic compounds in biological systems comprising the use of specific antibodies , for use in different protein detection systems . in an ongoing study , the usefulness of spiggin antibodies to detect androgenic effects in pulp mill effluent waters is investigated . preliminary results confirm that spiggin is a good androgenic biomarker . another embodiment is a method for the detection of androgenic compounds in biological systems comprising the use of the spiggin cdna in mrna detection systems . in an ongoing study , the usefulness of spiggin mrna to detect androgenic effects in pulp mill effluent waters is investigated . preliminary results confirm that spiggin is indeed a good androgenic biomarker . furthermore , specific peptide sequences are to be used as standards in antibody detection systems to allow proper quantification of spiggin . according to one embodiment of the invention , the peptides used for production of the antibodies are used as control standards in the detection of androgenic compounds . one embodiment of the invention is a western blot method to detect spiggin protein comprising the following steps : 1 ) collection of a kidney or urinary bladder sample from stickleback and mixing it with gel loading buffer , 5 ) incubation with primary antibody directed against native spiggin , synthetic spiggin peptide , or recombinant protein , another embodiment of the invention is an enzyme linked immunosorbent assay ( elisa ) comprising the following steps : 3 ) dilution of positive control consisting of native spiggin , synthetic peptide or recombinant protein in coating buffer , 5 ) addition of positive control to three wells each to create a standard curve , 10 ) dilution of primary antibodies ( against native spiggin , synthetic peptide or recombinant protein ) in blocking / dilution buffer and addition to each well , 13 ) dilution of secondary antibody in blocking / dilution buffer and addition to each well , another embodiment of the invention is a kit for the detection of androgenic compounds , comprising at least antibodies raised against one or several synthetic peptides designed against antigenic epitopes of the protein , synthetic protein or recombinant protein and the specific peptide or peptides as standard . according to a further embodiment , the necessary components for elisa ( enzyme linked immunosorbent assay ) detection are also included in such a kit . an elisa kit according to the invention would preferably comprise the following : 2 ) synthetic peptides or recombinant protein designed against antigenic epitopes of the protein , 9 ) secondary antibody directed against rabbit for polyclonal primary antibody or mouse for monoclonal primary antibodies , 10 ) detection substrate such as horseradish peroxidase substrate or other equivalent substrate , 11 ) specification chart for the primary and secondary antibodies and the peptide standard , and 12 ) a manual containing instructions for use and requirements of additional components . a kit according to the present invention may also comprise only part of the above listed components , the necessary components being antibodies or standards , produced using the inventive protein and / or information derived thereof , such as the sequence data disclosed herein or homologous sequences , including functionally equivalent sequences . according to further embodiments of the invention , the adhesive protein or protein complex is used in medical applications , for example as a component in wound dressings and bandages , in particular in such applications where the biodegradable properties of the protein are needed . due to spiggin being a viscous adhesive protein that functions in water and other moist environments it could be used e . g . for antibiotic therapy and coating of dressings . by mixing the protein with selected pharmaceutical compounds , a slow release composition is achieved . the adhesive properties also aid in immobilising the pharmaceutical to a specific location of the skin or in the body of a patient , undergoing treatment . since the protein has an ability to attach to surfaces , and to form an attachment between surfaces , it may be used as a tissue adhesive . the capability of attaching paper and latex samples to human skin shows that spiggin also may be used as an adhesive for plasters , adhesives , bandages , patches and dressings etc . the protein may also be useful in orthopaedics as a glue to keep or hold joint replacements together . among other uses of this protein is the possible use as a biomechanical shock absorber due to its viscous nature . such biomechanical components include artificial cartilage , intervertebral discs and / or parts thereof . there is at present no glue / paste or cement that works well under water . since the protein has an ability to attach to surfaces , and to connect surfaces , as tested by attaching small pieces of wood to each other in a wet environment , it may be used as an underwater adhesive / glue . in addition to being used as an underwater glue or adhesive , the protein may also be used as an underwater sealant . one embodiment of the present invention is the application of the adhesive protein as such , derivatives thereof or information derived thereof for the production of a glue or an adhesive for use in moist environments . moist environments in this context include both aquatic environments , objects and surfaces in contact with water ; sea water , fresh water , high humidity , steam and / or condensation . the applications can be found in both natural or man - made environments and even on or within an animal or human body . amino acid analysis was performed on the 203 kda region from gene electrophoresis by ion - exchange chromatography as described by jakobsson et al ., fish physiol biochem 20 : 79 - 85 ( 1999 ). one potential n - terminal and several potential internal sequences were obtained . these were spiggin 1 ( ktkeiqty ), spiggin 2 ( kavlsihpdfsvvk ), spiggin 3 ( kenyishk ), spiggin 4 , ( syyvr ) spiggin 5 ( rgtfsir ), spiggin 6 ( lyirk ), spiggin 7 ( irdpvlrk ) and spiggin 8 ( tayswv ). of these , sequence 1 , 4 , 5 and 6 were confirmed to be spiggin following cloning of the cdna . hormones at different concentrations were dissolved in 100 ml of coconut oil and placed within silastic capsules ( dow corning , internal diameter 0 . 6 mm , outer diameter 1 . 2 mm , length 5 mm ). the sealed capsules were implanted into the abdominal cavity of each fish which were subsequently placed in aquaria containing 200 l of brackish water ( 0 . 5 % salinity ) at 17 ° c . under a stimulatory photoperiod of l : d 16 : 8 . following one month exposure the fish were sacrificed and the required organs removed by dissection and stored at − 70 ° c . total rna was extracted from all tissues using tri reagent ” ( sigma ). the mrna fraction was isolated using the poly ( a ) quik ′ mrna purification kit ( stratagene ). all preparations were stored at − 70 ° c . complementary dna was synthesised from 0 . 5 mg of total rna using the first strand cdna synthesis kit ( amersham pharmacia biotech ). pcr was performed with 500 ng of cdna termplate in a final volume of 50 ml . the reaction mix contained 0 . 2 mm dntps , 5 ml 10 × reaction buffer , 2 . 5 nm of magnesium chloride , 1 . 25 u of taq dna polymerase and 25 pmol of spiggin 1 ( 5 ′- caraciaargaraticarac - 3 ′) and spiggin 3 ( 5 ′- ttrtgigaiatrtarttytcytt - 3 ′) oligonucleotides . following an initial denaturation step at 95 ° c . for 3 min , amplification was performed at 95 ° c . for 1 min , 50 ° c . for 1 min , 72 ° c . for 1 min for 40 cycles . pcr products of approximately 600 bp were generated which were visualised by agarose gel electrophoresis according to sambrook et al ., molecular cloning : a laboratory manual , 2 nd ed . ( 1989 ). all generated rt - pcr products were ligated into pgem - t ′ ( promega ) and transformed in competent e . coli cells according to sambrook et al ., ( 1989 ). positive colonies were grown under antibiotic selection over night and recombinant plasmids were isolated using the wizard ′ plus sv miniprep system ( promega ). cycle sequencing was performed using the thermo sequenase v2 . 0 sequencing kit ( amersham pharmacia biotech ). the reactions were resolved on an abi prism ″ 377 dna sequencer ( perkin elmer ) and the data obtained analysed using editview v1 . 0 . 1 ( perkin elmer ). 5 mg total rna was combined with 90 ml of 20 × ssc and 60 ml 37 % formaldehyde . the final volume was adjusted to 300 ml with mq water . each preparation was transferred onto nylon membrane ( amersham pharmacia biotech ) using a minifold ii slot blot apparatus ( schleicher & amp ; schuell ). the rna was bound onto the membrane by cross - linking in a cl - 1000 uv apparatus ( uvp ). membranes were radioactively probed as described below ( paragraph 10 ) and the relative levels of mrna were determined using a gs - 250 molecular phosphoimager coupled to the molecular analyst ( version 1 : 41 ) package ( bio rad ). all dose - response determinations were performed in triplicate and the results were expressed as the mean (± sd ) for each hormone and dose assayed . northern analysis of total rna was performed according to sambrook et al ., ( 1989 ) supra . membranes were radioactively probed and visualised as described below ( paragraph 10 ). total rna was extracted from mature male tissues , from three individual fish , using tri reagent ® ( sigma ). aliquots of 5 mg total rna were mixed with denaturing solution ( 6 × ssc , 7 % ( v / v ) formaldehyde ) and transferred onto nylon membrane ( amersham pharmacia biotech ) using a minifold ii slot blot apparatus ( schleicher and schuell ). membranes were probed using a randomly primed [ a32p ]- dctp radiolabelled spiggin cdna fragment ( 636 bp ) that was isolated by rt - pcr and sequenced as above . hybridisations were performed at 65 ° c . o / n ( 6 × ssc , 0 . 1 % ( w / v ) sds , 100 mg ml - 1 trna and 5 × derhardt &# 39 ; s solution ). the membranes were washed for 2 × 30 min periods at 42 ° c . and 65 ° c . in 0 . 1 × ssc / 0 . 1 % ( w / v ) sds and exposed to hyperfilm ®- mp film ( amersham pharmacia biotech ) at − 70 ° c . the films were visualised using a curix 60 filmn developer ( agfa ). a cdna library was generated from the poly - a fraction of stickleback kidney rna which was isolated as described previously ( paragraph 3 ). the library was constructed in lambda zap express ′ ( stratagene ). screening was performed according to sambrook et al ., ( 1989 ) supra , using radioactive probing as described below ( paragraph 10 ). several individual clones were identified following four rounds . these were isolated according to the lambda zap express ′ instruction manual and sequenced as described below ( paragraph 9 ). initial sequencing was done as described in paragraph 5 to confirm the identity of individual spiggin cdna clones . the selected clones were thereafter sequenced by cybergene ab , huddinge , sweden ( 100 % patent sequencing ). all membranes were probed using a 600 bp [ a32p ]- dctp radiolabelled cdna fragment of spiggin which was previously isolated by rt - pcr ( paragraph 4 ). hybridisation was performed at 65 ° c . o / n in 6 × ssc , 0 . 1 % ( w / v ) sds , 100 mg ml - 1 trna and 5 × denhardt &# 39 ; s solution ( 0 . 1 % ( w / v ) bsa , 0 . 1 % ( w / v ) ficoll , 0 . 1 % ( w / v ) polyvinylpyrrolidone ). the membranes were washed for 2 × 30 min periods at 42 ° c . and 65 ° c . in 1 × ssc , 0 . 1 % ( w / v ) sds and exposed to hyperfilm ″- mp film ( amersham pharmacia biotech ) at − 70 ° c . o / n . the films were visualised using a curix 60 film developer ( agfa ). polyclonal antibodies were generated by agri sera ab . the following peptides were employed : spiggin ktk 16 ( ktieiqtytsrtfgs - c ) and spiggin hrd 16 ( hirdelirdshlhdhr - c ) which correspond to the n - terminal sequence and amino acid sequences at positions 149 - 164 , respectively of the spiggin protein . protein samples were resolved by sds - page at a constant current of 50 ma for 1 h according to laemnmli ( 1970 ) using 10 % and 5 % tris - glycine running and stacking gels , respectively . proteins were subsequently visualised by staining with coomasie brilliant blue , or silver nitrate according to sambrook et al ., ( 1989 ) supra . proteins were transferred onto nitro - cellulose membrane ( amersham pharmacia biotech ) following sds - page using the trans - blot ′ semi dry electrophoretic transfer cell ( bio rad ) at 15 v for 30 min in a buffer which consisted of 48 mm tris , 39 mm glycine and 20 % methanol ( ph 9 . 2 ). immunodetection was performed according to sambrook et al ., ( 1989 ) using sera raised against either spiggin ktk 16 or spiggin hrd 16 as primary antibodies ( paragraph 11 ) and rabbit immunoglobulin hrp conjugate ( dako ) as secondary antibody , respectively . proteins were visualised using the hrp substrate kit ( bio rad ). spiggin protein obtained from urinary bladders was tested for its ability to hold together biological material such as pieces of wood . this ability was tested by holding together the pieces and then determining if they would remain attached . the ability to adhere to human skin was tested according to the following protocol : the male stickleback has a high content of spiggin in its urinary bladder during the breeding season . three male stickleback were collected and their urinary bladder content extracted . this urinary bladder content will below be called “ spiggin ”. spiggin was compared to a solution of bovine serum albumin ( bsa ), mineral oil , and water for its ability to attach 1 cm 2 samples of kim ® wipe paper or latex ( cut from a surgical glove ) to human skin . the site of attachment was the lower side of the forearm of the testperson . the experiment was performed thrice . an initial test was performed using only spiggin and water and the samples observed for 60 minutes ( experiment i ). this was followed by two experiments where the samples were observed for 20 minutes ( experiments ii and iii ). at the end of each experiment , the samples were removed from the skin using a fine forceps . attachment was determined as none (−), very weak (+/−), weak (+), strong (++), and very strong (+++). if a sample detached on its own , the time to detachment was registered . juvenile three spined sticklebacks , with a body weight of approximately 100 mg , were exposed to different doses ( 100 pm , 10 nm and 1 um ) of methyltestosterone or to a combination of 10 nm methyltestosterone and 10 um flutamide ( an antiandrogen ). after 10 days the fish were sacrificed . whole fish were homogenized and spiggin mrna levels were determined using slot blot analysis . the results are presented in fig5 . in a separate experiment juvenile three spined stickleback were exposed to water samples collected from a swedish river and a pulp mill in this river . the fish were exposed to 10 × diluted pulpmill and river outlet water and undiluted incoming river water for 10 days . as a control a separate group was exposed to undiluted spring water . whole fish were analysed for spiggin mrna content using slot blot analysis . the methyltestosterone exposure was plotted to create a standard curve . the spiggin levels in the water exposed fish were compared to the standard curve and presented as nm methyltestosterone equivalents . the results are presented in fig6 . sequencing of the stickleback kidney cdna library revealed the presence of at least three splicing variants of the spiggin protein . these variants are encoded for by a 4 . 2 kb ( seq id no . 1 ), a 2 . 2 kb ( seq id no . 4 ), and a 1 . 6 kb ( seq id no . 8 ) mrna . northern blot analysis of 11kt induced stickleback kidney ( fig2 ) indicates that there are at least three different splicing variants , with the largest being the 4 . 2 kb mrna that has been cloned and the 1 . 6 kb mrna being the smallest . the stickleback spiggin glue protein is exclusively expressed in the kidney of sexually maturing male stickleback ( fig2 ) and is only inducible by 11 - ketotestosterone ( fig3 ). the largest cloned cdna codes for a 910 amino acid protein with a molecular mass of 103 ida , which surprisingly was found to be approximately 50 % of the previously determined size of spiggin in urinary bladder . the spiggin protein has been estimated to 203 kda in urine and has been shown to have some glycosylation resulting in a few percent reduction in molecular mass . to determine the reason for the discrepancy in molecular mass the present inventors produced 2 polyclonal antibodies . one was directed against the n - terminal region ktkieqtytsrtfgs ( amino acid 25 - 39 ) following the leader sequence , and the other was directed against an antigenic epitope located between amino acid 173 and 188 , hrdelirdshlhdhrc . using both these antibodies to detect spiggin in kidney and urinary bladder demonstrated that the antibodies detected the 203 kda urinary product while this product was not present in kidney ( fig4 b ). the largest protein detected in kidney was approximately 130 kda , which is in good agreement with the deduced protein encoded by the 4 . 2 kb mrna . several smaller components , probably reflecting both the splicing variants ( 51 kda and 90 kda ) and degradation produces were also detected on the western blots . detection of spiggin using coomasie brilliant blue staining also indicate that the 203 kda protein is not present in kidney but is a modified product , probably a dimer , that appears first in the urinary bladder ( fig4 a ). together these results show that the spiggin gene encodes for at least 3 splicing variants and that the largest of these has an unmodified molecular mass of 103 kda . furthermore this protein appears as a 203 kda product in urinary bladder , probably as a result of multimerisation . the spiggin protein has also been tested for its ability to hold pieces of wood together in a wet environment . the present inventors found that addition of spiggin resulted in attachment of the pieces . this is in line with the function of spiggin in nature where it is used by the male stickleback to glue together biological material to form a nest . the experiments evaluating the ability of spiggin to attach showed promising results . spiggin was able to firmly attach a piece of kim wipe paper in all three tests . spiggin attached latex had a fluid attachment for about 10 min before drying out and attaching the latex . the results are presented in the table below : the ability of spiggin to function as an androgenic marker was tested , both using different doses ( 100 pm , 10 nm and 1 um ) of methyltestosterone , a combination of 10 nm methyltestosterone and 10 um flutamide ( an antiandrogen ), and diluted pulpmill outlet water . in experiments evaluating the ability of spiggin to be upregulated by androgenic compounds via water it was found that methyltestosterone down to 100 pm was effective at inducing spiggin mrna . furthermore , the androgen specificity of the system was confirmed by the inhibiting ability of flutamide ( an antiandrogen ) when added together with to methyltestosterone . confirmation that androgenic responses are present in the environment was obtained by testing water from a river and a pulpmill . the river sampling point showed weak androgenic effects comparable to a 200 pm methyltestosterone exposure . this water is down stream of a major sewage treatment plant . higher levels of spiggin mrna induction was observed within the pulp mill with levels reaching 1400 pm methyltestosterone equivalents . finally , the ability of the pulp mill to purify the outlet water was observed by the lower androgenicity of the river outlet water . together these studies demonstrate that spiggin is a highly sensitive biomarker for androgenic effects . the results are presented in fig5 and 6 . although the invention has been described with regard to its preferred embodiments , which constitute the best mode presently known to the inventors , it should be understood that various changes and modifications as would be obvious to one having the ordinary skill in this art may be made without departing from the scope of the invention which is set forth in the claims appended hereto . met thr thr gln arg trp ile leu ala phe cys leu ser leu ala ser thr cys arg thr phe gly ser gly ile val gln pro phe lys gly glu ser tyr tyr val arg ser asp cys pro phe lys leu thr ser phe asn gln asn gly his ile leu val gln asn lys ser val ser leu pro tyr asp his thr tyr gln his ile phe lys tyr gly ile tyr thr arg leu arg ser ser leu leu pro phe thr val thr trp his asn val his gly gly ile asn ser leu trp val thr leu glu ser glu leu cys thr asp met cys gly leu cys gly lys gln asn val ala gly his arg asp glu pro val leu arg lys asn his ile cys arg arg phe phe leu lys thr ile tyr glu lys lys gly pro ala phe ile pro ser cys ser asn pro asn pro ala pro phe tyr gln glu leu thr glu thr cys ser cys pro glu gly lys val leu asn asn cys glu lys gly tyr arg cys ile pro trp arg cys ser glu asn phe cys his arg arg cys val ile glu gly gln phe val thr thr phe asp gly lys gln tyr val leu pro asn lys cys leu tyr val ala ser lys gly pro asn trp ile ile ile ile glu phe ser gln lys asn leu tyr ile arg lys val thr val gln leu met glu ile pro glu phe his phe ser gly his ala gln val tyr trp val ile gln met ser pro glu ile his leu phe ile asp ala pro asp pro pro phe ala met ser trp ser leu leu asn cys phe gly asn ile pro ala val leu asn gln pro thr gly ile phe ala lys cys his pro his ile thr gly cys asp leu lys cys gln lys asn gln glu phe ser tyr ile arg cys gly met asn asp asp ala val glu gly cys gly cys pro gly gln his lys arg val gln lys thr cys asp tyr ile ser lys pro lys gly thr arg glu asn cys lys ser gly cys tyr cys pro asp his gln tyr glu asp his his gly asn cys val ser leu asp asp cys thr asn cys lys thr cys thr cys tyr arg gly gln trp his cys ile glu thr phe asp ser lys trp phe arg phe ser gly gln cys leu tyr thr leu val gln asp ser cys asp met arg arg gly thr phe ser ile arg gln val thr arg arg leu his glu gly trp thr gly gln asp asp ser met thr thr gln arg trp ile leu ala phe cys leu ser leu ala ser thr cys arg thr phe gly ser gly ile val gln pro phe lys gly glu ser tyr tyr val arg ser asp cys pro phe lys leu thr ser phe asn gln asn gly his ile leu val gln asn lys ser val ser leu pro tyr asp his thr tyr gln his ile phe lys tyr gly ile tyr thr arg leu arg ser ser leu leu pro phe thr val thr trp his asn val his gly gly ile asn ser leu trp val thr leu glu ser glu leu cys thr asp met cys gly leu cys gly lys gln asn val ala gly his arg asp glu pro val leu arg lys asn his ile cys arg arg phe phe leu lys thr ile tyr glu lys lys gly pro ala phe ile pro ser cys ser asn pro asn pro ala pro phe tyr gln glu leu thr glu thr cys ser cys pro glu gly lys val leu asn asn cys glu lys gly tyr arg cys ile pro trp arg cys ser glu asn phe cys his arg arg cys val ile glu gly gln phe val thr thr phe asp gly lys gln tyr val leu pro asn lys cys leu tyr val ala ser lys gly pro asn trp ile ile ile ile glu phe ser gln lys asn leu tyr ile arg lys val thr val gln leu met glu ile pro glu phe his phe ser gly his ala gln val tyr trp val ile gln met ser pro glu ile his leu phe ile asp ala pro asp pro pro phe ala met ser trp ser leu leu asn cys phe gly asn ile pro ala val leu asn gln pro thr gly ile phe ala lys cys his pro his met thr thr gln arg trp ile leu ala phe cys leu ser leu ala ser thr cys arg thr phe gly ser gly ile val gln pro phe lys gly glu ser tyr tyr val arg ser asp cys pro phe lys leu thr ser phe asn gln asn gly his ile leu val gln asn lys ser val ser leu pro tyr asp his thr tyr gln his ile phe lys tyr gly ile tyr thr arg leu arg ser ser leu leu pro phe thr val thr trp his asn val his gly gly ile asn ser leu trp val thr leu glu ser glu leu cys thr asp met cys gly leu cys gly lys gln asn val ala gly his arg asp glu pro val leu arg lys asn his ile cys arg arg phe phe leu lys thr ile tyr glu lys lys gly pro ala phe ile pro ser cys ser asn pro asn pro ala pro phe tyr gln glu leu thr glu thr cys ser cys pro glu gly lys val leu asn asn cys glu lys gly tyr arg cys ile pro trp arg cys ser glu asn phe cys his arg arg cys val ile glu gly gln phe val thr thr phe asp gly lys gln tyr val leu pro asn lys cys leu tyr val ala ser lys gly pro asn trp ile ile ile ile glu phe ser gln lys asn leu tyr ile arg lys val thr val gln leu met glu ile pro glu phe his phe ser gly his ala gln val tyr trp val
an adhesive protein , present inter alia in the stickleback nest building glue has now been isolated and purified . its amino acid sequence and corresponding coding polynucleotide sequences are isolated and sequenced . the protein finds both medical and technical uses , whereas both the protein and the polynucleotide sequence can be used in analyses , determining the presence and influence of androgenic substances , for example androgenic pollutants , present in the aquatic environment .